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f&ctiw~. Ilk study reports the long-term outcome of pa- 
tients undet@nB percutaneous balloon mitral commissurotomy 
who were enrolled in the Nationai Heart, Lung. and Blood 
Institute (NHLBI) Balloon Valvuloplasty Registry. 
Ed-m. lhe NHLBI established the multkenter Balloon 
Valvuloplasty Registry in November 1987 to assess both short- 
and long-term safety and eBkiency of percutaneous balloon mitral 
commissurotomy. 
Methods. Between Novembr 1987 and October 1989. 736 
patients ~18 years old undement percutaneous balloon mitral 
commissurotomy at 23 registry sites in North America. The 
maximal follow-up period was 4 2 years. 
ResudLs. The actuarial survival rste was 93 +. 1% (mean f SD), 
90 f 1.2%. 87 f 1.4% and 84 + i.6sZ at 1, 2, 3 and 4 years, 
respectively. Eighty pemnt of the patients were alive and free of 
mitral surgery or repeat balloon mitral commissurotomp at I year. 
P~KUtilllL!~NlS halloon mitral commissurotomy. first described 
hy Inouc et al. (I) in IW, has been shown (7-4) to produce a 
satisfactory hemodynamic result in patients with rheumatic 
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The event-free survival rate was 80 2 I.!% at 1 year, ‘II i 1.7% at 
2 years, 66 + 1.8% at 3 years and 60 f 2.0% at 4 years. Important 
univariable predktors of actuarial mortality at 4 years included 
age ~70 years WZ survival), New York Heart Association 
functional class fV (41% survival) and baseline ecbocardioquphk 
score >I2 (24% survival). Multivariabk predktors of mortality 
in&ted functional class IV, higher ecbocardiqraphk scorn and 
higher postproccdunl pulmonaty artey systdic awl left veatrk- 
ular eud-diastdk pressures tp c 0.01). 
Omch4sitm. Percutaneous balloon mitral commissurotomy 
has a favorable e&t on the hemod.ynamk variables of mitral 
stenosis, and long-term follow-up data su~fest tbut it is a viable 
alternative with respect to suqkal commissurolomy in selected 
patients. 
(J Am Cdl Cat&d 19%:28:1552-7) 
mitral stenosis. Long-term follow-up data for these patients at 
various centers appear to bc favorahle (5.6). However, many of 
these centers are outside North America. and their patients are 
gcncrally younger and have fewer comorbid diseases and more 
favorable valve pathology. These factors may lead not only to 
ditferent short-term results hut also to posaihlc diffcrcnces in 
long-term follow-up data. 
The National Heart. Lung. and Blood Institute funded the 
Balloon Valvuloplasty Registry in November 1987. The pur- 
pose of the registry was to crllect detailed baseline and 
postprocedural data and to provide long-term follow-up infor- 
mation on patients undergoin; the procedure at 23 centers in 
North America (24 centers were involved in the registry: 
however, one dtd not ‘enroll patients in the mitral registry. The 
present report provides long-term follow-up information for 
patients undergoing this procedure in the Registry. The in- 
hospital and 30-day hemodynamic and clinicai outcomes have 
been previously reported (4,7). 
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Methods 
Da& collection. Percutaneous balloon mitral commissurot- 
omv was performed at the individual sites under institutional 
review board approyal. All patients ~18 years old undergoing 
the procedure at the registry sites were included in the registry. 
Of the original 73H patient:, who were identified. 2 wcrc noted 
on review to have been enrolled twice at digerent ccntcrs. 
Thstcforc. this report provide3 follow-up data for 73h patients. 
Details regarding data collection have been reported else- 
where (4). 
Follow-up information was ohtained 9 hospital discharge. 5 
weeks after the procedure and thereafter at 6-month internals 
until October 31. 1092, when the registry was closed. The 
maximal follow-up period was 5.2 years (mean [zSD] 3.2 2 
1.3). The data were collected on a standardized form hy il 
research nurse at each clinical site. Events (e.g., death. repeat 
percutaneous Moon mitral commissurotomy, valve surgery) 
were collected at the follow-up visits. The records of all 
patients who died were reviewed hy a mortality review com- 
mittee for adjudication of cause of death. 
Statistical analysis. Clinical status was reported at hase- 
line, 6 months and yearly thereafter. The status of patients who 
died was considered “worse” than that at hastline. Results 
were censored at the time of mitr:J-xtlve surgery or repeat 
balloon mitral commissurotomy. Data are reported as mean 
value tSD. 
Kaplan-Meier time to event curves were constructed for 
twn outcomes: 1) sutvival. censored at mitral valve surgery or 
repeat halloon mitral commissurotomy; 3) event-free survival. 
with event defined as mitral valve surgery or repeat balloon 
mitral commissurotomy. Rate estimates. standard errors and 
9% confidence intervals arc reported for each year of follow- 
up. Event rates in subgroups determined by baseline and 
postprocedural variables were compared by the log-rank test. 
Multivariate Cox regression was used to identify indepen- 
dent predictors of the three outcomes. Because the large 
number of potential covariates. separate stepwise models were 
initially constructed for clinical, echocardiographic. catheter- 
ization and “miscellaneous” data. Variables that were signifi- 
cant at p = 0.05 in these analyses were then considered for 
inclusion in the overall models. Interactions between selcctrd 
variables were allowed to enter if they had additional predic- 
tive power. The proportional hazards assumption was veriiicd 
by stratification of the final mcwlels by each independent 
variable. 
Results 
Patients. The mean age of the patients was L94 ,Z 15 years, 
and 81% were female. The mitral valve area incrcased‘from 
1.0 .Z 0.3 cm2 before the procedure td 2.0 2‘ 0.H cm’ aft& the 
procedure. Details of the hemodynamic and early clinical 
outcomes have bet%reportcd elsewhere (133). Echocardio- 
graphic assessment (performed at the study site) showed a 
mitral valve area of LOY + 0.29 cm’ before the procedure, 
oyMI* 1 *mar 2 rawa 3 Ymln 
Firr 1. k Percentage ul patients in NW York Heart AsuuGion 
(NYHA) functional clastis I to IV More h;lll(Mln miW commissur- 
otumy. at b months and,yc,ariy therrafrer to 3 years. Nope that the 
majority of patienrs remam m funcrionrl class 1 throughout f&nv-up. 
B, Percentaq of patients after halimn mitral commissurotomy who 
report their overall health status as hettcr. thr: same: or wxw than at 
hasclinc (vs. haselinc status ;It h monlhs and Ihen yctirlp thrreaficr to 
3 vexs). Their impression oi original ttt~ri;ll hr#h stalus closely 
m&s the pcrccnragcs in functional clasps I dnd Ii. 
which improved 10 I.80 z 0.l.C cm’ after the procedure and 
declined IO 1.M f 0.48 cm’ al h-month rchtudy (p c: O.UMll). 
Clinical symptoms: functional crpaciQ. As depicted in 
Figure 1 A. 64% of patients were in New York Heart Associ- 
ation functional class 111 or IV before the procedure. At 6 
months there was a marked reduction of symptoms. with Xl!? 
of patients in functional class 1 or 11 and only 11Q remaining 
in functional class III or IV and 8vc dead. The percent of 
patients in functional class I or Ii remained remarkably stable 
during follow-up. Functional improvement was also reflected 
in the overall health status as perceived by the patient. >6S% 
of whom reported feeling better throughout the follow-up 
period (Fig. IB). 
Survival, Thr survival rate was 93 2 1Wi at 1 year. 90 2 
i .2vc at 2 years, 87 2 1.4% at 3 years and 83 -C 1.6% at 4 years 
(Fig. 2). Of the 122 registry patients who died. the cause of 
death was determined in 112 (YZT). The most frequent cause 
of death was cardiac (71%). with congestive heart failure the 
most common (29%). Survival in elderly patients >70 years old 
was worse than that in younger patients at all periods of lime. 
At Cyears of follow-up. the survival rate was 89% in those 170 
years old verslis 51% in those’ >70 y old. In addition, survival 
was higher in women than men; at 4 years. 87% of women 
compared with 73% of men were alive (p = Wl3). Patients in 
functional classes I and II did equally well at follow-up. 
However, only 41% of patients in functional class IV before 
the procedure were alive at 4 years (p < O.(lnMl). The effect of 
Fire 2. Overall survival: censored at mitral valve surgery or repeat 
halloon mitral commissurotomy in those patients after percutaneous 
Fiirr 4. Time to mitral valve surgery after percutaneous balloon 
halltnn mitral commiFsurotnmy. 
mitral commissurotamy. Thcrc is continued risk thmtghout the 
f0lltr~-up period 
ft!trctional class at S weeks of follow-up on subsequent oul- 
come was similar. Patients with atrial fibrillation and those with 
ic history of embolic events likcwisc had poorer survival (78% 
v?. KY% and 70% vs. 87%. rcspeclively. at 4 years). 
Baseline echoeardiographic score also affected long-term 
survival (Fig. 3). The survival rate in patients with severely 
diseased mitral valves (i.e., echocardiographic score >I2 (81) 
was only 24% at 4 years. Patients with an eehocardiographic 
score 28 also tended to be older than those with a score ~8 
(SH 2 IS vs. 49 z 13 years, respectively. p < 0.0001). 
Echocardiographic assessment of left ventricular systolic func- 
tion revealed that patients with reduced function did not do as 
well (survival rate 87% vs. 63% at 4 years for normal vs. 
reduced function respectively, p < O.ooIll). 
In the early experience of the registry, 114 patients had 
balloon mitral commissurotomy performed with a single, non- 
Inoue balloon catheter. These patients did not do as well as 
those undergoing the procedure with two balloons (survival 
rate 88% vs. 62% for double vs. single balloon, respectively, at 
4 years). On average, these patients had a smaller change in 
mitral valve area, and fewer had a valve area ~1.5 cm’. It is 
likely that this suboptimal result probably explains most of 
their poor outcome, but they also did poorly at follow-up after 
single-balloon commissurotomy despite a valve area > 1.5 cm’ 
Fire 3. Survival by baseline echocardiographic score: <8 taolid 
line), 8 to 12 (short drabad liac) and echocardiqraphic score >I2 
(long dashed line). p s: O.Mol (log rank statistic 133.67.C), 
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compared with those patients undergoing a two-balloon pro- 
cedure. 
For the overall registry, high volume centers (i.e., those 
performing > Ill0 procedures) have the best survival at follow- 
up. However. when these data were stratified by year of 
enrollment, the effect was greatest during the first year, and by 
year 2 there were no differences between centers with respect 
to low, medium or high volume (p = 0.23). 
Event-free survival. Event-free survival, defined as free- 
dom from death, mitral valve surgery or repeat balloon mitral 
commissurotomy, was 80 2 1.5% at 1 year, 71 + 1.7% at 2 
years, 66 2 1.8% at 3 years and 60 2 2.0% at 4 years. At 4 
years, 72% of patients were free from mitral valve surgery after 
balloon mitral commissurotomy. Figure 4 depicts time IO 
operation. Although the risk is greatest early after the proce- 
dure, there is constant hazard throughout the follow-up period. 
Multivariate analysis. Multivariate predictors of death 
during follow-up (Table 1) show that functional IV, higher 
echocardiographic score, higher postprocedural pulmonary 
artery, and left ventricular end diastolic pressures and use of a 
single balloon catheter were all predictors of survival. Table 2 
depicts the multivariable predictors of event-free survival (i.e., 
freedom from death, operation and repeat balloon mitral 
commissurotomy) during follow-up. Similarly, a higher pulmo- 
nary artery pressure, smaller balloon diameter (total halloon 
pair diameter with double b&on) and a smaller mitral valve 
area after the procedure were all predictive of poor outcome. 
Table 1. Multivariable Predictors of Death During Follow-Up 
(censored at mitral valve surgery and repeat balloon mitral 
commissurotomv) for 494 Patients 
Variable p Value liad Ratio (95% Cl) 
NYHA functional class tV < o.mn S.H7 (3.16-10.8X) 
F.&l score Zlll <o.wm 4.34 (2.33-8.07) 
Post-PA pressure Ml mm Hg <0.alo1. 3.?6(2.00-7.07) 
Single b&on ‘o.oMl6 
Post-LVRDP >iSmmHg : 
3.28 (1.67-6.44) 
0.l 2.40(1.24-4.61) 
Cl = congdence interval;’ Echo = echoear&graphic; ‘LVEDP = left 
vcntmzular enddiastdi pressure; NYHA = New York Heart Asanciation; PA = 
pulmonary amy; PIXI- = Postprocedural. 
T&k 2. Multivariate Prcdiaon c)f Ewnt-Free Sunk.11 During 
Follow-Up for 581 Pihmts* 
Vkiahlc p Value HazxJ Rario (9% Cl) 
NYHA functional clw (I-IV) .I NIYYII l.R(I.J(I-2.17) 
PO+PA prcwrc :rUl mm IIg .- (1.111~1 ‘..c (I .7b-3.33) 
MV gradient dccrraw ‘. II.lYYlI 2.44 (I.711 -3.51) 
-: Ill mm Iig 
Po*I.MV arc3 . . . I.5 cm2 11.(N) I !.hN(1.~4’3) 
Balkan didmetcr 0 mm IJK 2.11 (I.l.L?.W) 
‘Evcn~ = dcalh. milral valve surgcty or rqxrt halhrm mitral ccrmmissurot- 
omy. MV = mitral valve: otlxr ahbrcviations as in Tahlc 1. 
Functional class wds associated with event-free survival such 
that for every increase in functional class from I to IV. the risk 
increased concomitantly (i.e.. for class 1 the hazard was 1 .O and 
5.64 for class IV). 
Discussion 
We report the results in 736 patients undergoing percuta- 
neous balloon mitral commissurotomy at the NHLBI Balloon 
Valvuloplasty Registry sites in North America. To our knowl- 
edge, tnis is the largest report of prospectively collected data 
on patients undergoing this procedure. The maximal follow-up 
period was 5.2 years (mean 3.2 2 1.3). Although the present 
data represent information from a nonrandomized but pro- 
spective registry. they are nonetheless helpful in assessing the 
long-term outcome of patients undergoing this procedure. The 
registry data have several advantages, including enrollment of 
patients from many institutions rather than a single-center 
experience and patients with varying severity of disease, and 
probably represent a more “real world” assessment of the 
procedure. 
The initial hemodynamic results are similar to those previ- 
ously reported with the double-balk m technique described by 
Lock et al. (3) and Al Zaibag et al. (9). It is also similar to the 
hemodynamic results obtained after use of the Inoue single- 
balloon mitral valvuloplasty catheter (10-12). Of note, the 
Inoue balloon was not available during the registry period. The 
improved hemodynamic results mirror improvement in func- 
tional classification as well as the patients’ overall feeling of 
well-being after the procedure. There was remarkable consis- 
tency in the petcent of patients who improved after the 
procedure at each time period of follow-up. 
sorvivrl. ,The ovet$l survival rate was excellent, being 
93% at 1 year and 84% at 4 years. Event-free survival likewise 
is good. Predictors of death during follow-up are generally in 
‘agreement with previously published results from smaller 
groups of patients (13): except that we found that use of a 
single balloon (non-Inoue) predicted a lower survival rate 
during follow-up even when adjusted for postprocedural mitral 
valve area. It appears that patients with the most severe valve 
disease, manifest by high echocardiographic scores, severe 
preprocedural symptoms and a high postprocedural left ven- 
tricular end-diastolic pressure are those who do not do well at 
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follow-up. This outcome may be, due to the’increased p&load 
resulting from the procedure in the stting of .underlying 
diastolic d>3function from other causes, such as hypertensiun. 
aortic stenosis or valvular regurgitation. This finding is in 
agreement with previous reports (13). 
Patients who wele the most symptomatic before the proce- 
dure and those who had continued pulmonary hypertension or 
minimal changes in transmitral gradient after the procedure 
were most likely to have an event during follow-up. 
Although we did not evaluate the effect of residual tricuspid 
regurgitation on s&sequent outcome, it has heen reported 
(14) to have a negative impact. It appears that despite a good 
result after mitral commissurotomy. patients with severe tri- 
cuspid regurgitation do poorly during follow-up despite im- 
proved mitral henlodynamic status. This factor may have 
impacted the results of the registry because tricuspid regurgi- 
tation. if present. would have afftited the outcomes of these 
patients and is clinically more likely to be present with more 
severe, long-standing disease. 
Mitral valve surgery as an event remained a continued risk 
throughout the follow-up period. It is well established that the 
rheumatic process is not altered by this procedure or, for that 
matter, by surgical commissurntomy; therefore, it would be 
expected that patients would undergo mitral valve surgery as a 
result of progression of the underlying disease process. The 
multivariate predictors of mitral valve surgery are all consistent 
;vith a par result of balloon mitral commissurotomy. Our 
results suggest that patients will require opcra!ion if the 
percutaneous proccdurc lcads to an inadequate result. Of 
those undergoing operation, K4% had mitral valve replace- 
ment, not surgical commissurotomy. 
Comparison with other studks. It is difficult to compare 
the results from this registry with those from other reports 
because the patient group are potentially very different. The 
unique feature of this registry is that it reports experiences 
across the North American continent involving a very heter- 
ogenous cohort. Reports of the experience with both surgical 
and percutaneous mitral commissurotomy in more homoge- 
nous populations, such as those seen in Asia and South 
America, are likely to be different. Generally, patients in these 
countries are younger than those reported in NHBLI experi- 
ence. This younger age in turn may reflect a lesser extent of 
valve pathology, potentially resulting in less subvalmlar dis- 
ease, calcification and severe deformity of the valve. Further- 
more, the primary pathologic finding in these younger patients 
is likely to be fusion of the mitral commissures. thereby making 
these patients more amenable to commissurotomy techniques. 
In’addition. younger patients generally have fewer comorbid 
diseases. The patients in the NHBLI registry represent a cross 
section of patients, some of whom would have been deemed 
not suitable for commisurotomy, either surgically or percuta- 
neously. When these considerations are taken into account. the 
results from the NHBLI registry are comparable to previously 
published results (U-17) in patients undergoing the procedure 
in other countries. 
Several impbrtarit questions cannot be answered by this 
14.M ‘DEAN ET AL. 
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rcgist?. including comparison of the percutaneous approach 
ujth the established surgical’ procedures of closed and open 
commi&rotomy; The limitations of using a registry cohort to 
an&r ~hesc issues are well apprcciatcd. Comparison of 
nonrandomizcd groups of patients undergoing different proce- 
dures is difficult because of the potential bias in patient 
selection for various procedures and the diffcrcnt patient 
groups involved. 
However. there have been a small number of randomized 
trials (18-21) suggesting that the percutaneous procedure is 
comparable to open and closed surgical mitral commissurot- 
omy in similar patients. In a recent report by Reyes et al. (22) 
of a group of 60 patients randomized to open surgical com- 
missurotomy versus percutaneous balloon mitral commissur- 
otomy. similar results were obtained at J-year follow-up. 
Interestingly. the ballcon commissurotomy group, in prneral. 
had a larger mitral valve area than the surgical group. Only one 
patient with a balloon mitral commissurotomy died during 
follow-up. Those patients also did well clinically: 72% of 
patients in the balloon mitral commissurotomy group and 57% 
of those in the open surgical commissurotomy group *‘ere in 
functional class 1 at 3 years. Although that was a small 
randomized study comparing the two techniques. it nonethe- 
less strongly suggests that in appropriately selected patients. 
the procedures are probably equivalent. It must be stated that 
that was a select group of patients. very dissimilar to those in 
3ur registry. Their mean age was -3) years, all were in sinus 
rhythm, and all patients in the trial were deemed excellent 
candidates for commissurotomy with suitable mitral valve 
pathology. 
Conclusions. We reported lhe results of percutaneous 
balloon mitral commissurotomy in a heterogenous group of 
patients undergoing the procedure at multiple centers in North 
America. Our results indicate the importance of appropriate 
patient selection. Younger patients with lower echocardio- 
graphic scores and those who were less symptomatic before the 
procedure generally have excellent results that are maintained 
throughout follow-up. In older patients and those with severe 
preprocedural symptoms and higher echocardiographic scores, 
rspecially >12, the procedure appears to be more palliative. 
These patients do poorly in follow-up and if otherwise deemed 
candidates for surgical valve replacement, this is perhaps the 
preferred approach. However, even in this subgroup of pa- 
Gents there will be a small group of patients who cannot 
undergo surgical correction for various reasons. and the use of 
this technique for palliation seems reasonahlc. 
The patient population in North America with rheumatic 
heart disease is small compared with other geographical areas 
of the world. Therefore, on the basis of previous reports (7), it 
seems prudent that this procedure be performed by individual 
centers experienced in the technique. 
The Inoue balloon catheter (Toray, Inc.). recently approved 
by the Food and Drug Administration for the percutaneous 
relief of mitral stenosis, was not available during this registry 
experience. Although this catheter makes the procedure less 
technically difficult and probably decreases the complications 
askated with the procedure. (in particutsr, left ven!ricll!ar 
perforation and famponade) (2j). we suspect that itsuse would 
not have affected the subsequent outcome of our patients. It 
appears that obtaining an adequate hcmodynamic result is the 
most important predictor of subsequent events during 
follow-up and may have littlc to do with the actual catheter 
system used. 
There is mounting evidence both by retrospective analysis 
(243) and prospective randomized trials (22) that the use of 
this technique in patient: with severe, ‘symptomatic mitral 
stenosis is a viable alternative to surgical commissurotomy in 
selected patients. 
Wr thank Linda Plhlk for lypinp ths manuarip1. 
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